Credits: 0.25 AMA PRA Category 1 Credit™

Overview: In this episode, we discuss the findings of a recent Lancet publication on a novel neurokinin 3 (NK3) receptor antagonist for treating hot flashes. Tune in as we talk about how this nonhormonal treatment addresses menopausal hot flashes, the prescribing precautions issued by the FDA, and the implications for patients seeking your help with alleviating symptoms.

Episode resource links:

• Lancet 2023; 401: 1091–102. doi.org/10.1016/ S0140-6736(23)00085-5

Guest: Robert A. Baldor MD, FAAFP